Is the cohort of paradigm-hf representative of the real world population of patients with systolic heart failure?
23 May 2016 (08:48 - 08:54)
Organised by:
Abstract
Slides
About the speaker

Hospital Santa Cruz, Lisbon (Portugal)
13 More presentations in this session
Doctor G. Marazzi (Rome, IT)
MTP-131, a cardiolipin-targeting peptide, improves mitochondrial activity in the failing human heart
Doctor B. Stauffer (Aurora, US)
Professor S. Stoerk (Wuerzburg, DE)
Access the full session
The Event
HEART FAILURE 2016
23 May 2016
08:48 CET
